NAT10 as a potential prognostic biomarker and therapeutic target for HNSCC

Table 1 Clinical pathological parameters of the Chinese HNSCC cohort defined by the NAT10 expression signature

Clinical-pathological parameters	NAT10 negative	NAT10 low	NAT10 high	P value
Age				0.001
< 65	25	72	109
≥ 65	3	11	47
Gender				0.213
Male	24	48	95
Female	4	35	61
Site				7.35E−09
Oral cavity	10	64	141
Oropharynx	18	19	15
Smoking				0.058
No	15	55	114
Yes	13	28	42
Alcohol				0.476
No	19	67	124
Yes	9	16	32
Stage				0.149
I&II	20	57	95
III&IV	8	26	61
HPV				0.212
Negative	25	74	146
Positive	3	9	10
Grade				0.102
G1	15	40	59
G2	10	36	84
G3	3	7	13
Type				0.004
Primary	26	74	119
Recurrent	2	9	37

ISSN: 1475-2867